Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma

OBJECTIVE: Several anti-programmed cell death 1 (anti-PD-1) antibodies have demonstrated potential efficacy in the treatment of advanced esophageal squamous cell cancer (ESCC). However, the response to subsequent chemotherapy after the failure of PD-1 blockade in ESCC patients has not been reported,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Wang, Xi, Li, Qun, Mo, Hongnan, Wang, Xingyuan, Song, Yan, Xu, Jianping, Qu, Tao, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955162/
https://www.ncbi.nlm.nih.gov/pubmed/31949393
http://dx.doi.org/10.21147/j.issn.1000-9604.2019.06.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955162/
https://www.ncbi.nlm.nih.gov/pubmed/31949393
http://dx.doi.org/10.21147/j.issn.1000-9604.2019.06.07

Ejemplares similares